{
    "2019-08-21": [
        [
            {
                "time": "",
                "original_text": "港股通北水追捧建行、中国生物制药、工行、金山软件",
                "features": {
                    "keywords": [
                        "港股通",
                        "北水",
                        "建行",
                        "中国生物制药",
                        "工行",
                        "金山软件"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "重庆城投建信违规吃警示函 基金未按约向合伙人信披 金融监管处罚",
                "features": {
                    "keywords": [
                        "重庆城投",
                        "建信",
                        "违规",
                        "警示函",
                        "基金",
                        "信息披露",
                        "金融监管",
                        "处罚"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}